top of page
Brain Scans
Innovation in Oncology

Numiera is a preclinical-stage pharmaceutical company focused on developing small-molecule therapies for oncology indications. We are committed to improving patient outcomes by advancing a new class of treatments for malignant brain tumors.

Advancing Healthcare

At Numiera, we are passionate about discovering new treatments for cancer patients. By deeply understanding tumor biology, the vulnerabilities of cancer cells, and the key reasons many other potential interventions have failed, we have crafted a new strategy to drastically improve treatment options for cancer patients.

We are bridging basic research findings

toward oncology clinical trials

to bring new therapies to patients.

We rely on a deep understanding

of cancer cell metabolism

to develop novel therapeutics.

We use a state-of-the-art

preclinical platform technology

to test our novel therapeutics

We are committed to working with

clinical providers and patient advocates

to find better treatments for cancer.

bottom of page